Small Molecules

The US opioid crisis has claimed the lives of hundreds of thousands. We examine pharma’s role.

Why are people still being prescribed giant tablets?

Denis Hunn from ystral takes us inside the world of the mixer, highlighting how technologies have changed over the years.

Sitting Down With... Chip Davis, President and CEO of the Association for Accessible Medicines (AAM).

Pharma companies have been raising awareness for years, but patients continue to buy counterfeit medicines online.

From patient-centric design to speciality excipients and security of supply; what are the latest trends in formulation strategies?

How to manufacture your API in the right quantity, at the right cost, and in the right time frame.

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

Meet CPI: the UK not-for-profit dedicated to de-risking innovation.

Do you want to share the story behind your technology in a future issue of The Medicine Maker?